Vaccine trials in melanoma – time for reflection

Alexander Eggermont

The disappointing results of the large, randomised controlled trials showing no benefit of vaccines in patients with advanced and metastatic melanoma call for a reassessment of the development of therapeutic vaccines and the importance of better immune monitoring methodology, such as adoptive T-cell therapy with lymphodepletion.

Download full article

Be the first to comment

Leave a Reply

Your email address will not be published.